Loading use case index…
Loading use case index…
AI use case
Landing Med provides AI-powered cervical cancer screening solutions using computer vision analysis of cytological pathology images combined with cloud and edge computing for rea…
Core facts from this catalog record. Primary narrative lives in the hero above; full raw fields follow in the next section.
Every column from the source row, in stable order. URLs open in a new tab.
Title
Landing Med On-premise AI Cervical Cytology System — 10M+ Samples Trained
Content
Landing Med provides AI-powered cervical cancer screening solutions using computer vision analysis of cytological pathology images combined with cloud and edge computing for real-time diagnostic support. The platform has enabled over 12 million cumulative screenings and supports a remote pathology network covering 91% of underserved and remote areas in China. The AI system analyzes cell samples to identify precancerous lesions and cervical cancer indicators, providing screening results in near-real-time to rural and remote medical institutions that lack specialized pathologists.
Continue exploring AI deployments in the catalog.
Back to use casesCity
Shenzhen
Company/Organization
Landing Med
Continent
Asia
Country
China
Category
Health Care Technology
Type
Deployment
Id
770d6a19-9292-4c33-ac39-61d1ac9181d8
Created At
2026-04-04T15:00:29.555299+00:00